Companies: 10,795·Total market cap: $144.5T
Repligen Corporation

Repligen Corporation

RGENNASDAQHealthcare● Active
$122.31
$-4.24(-3.35%)
Market Cap$6.9B
P/E Ratio—
52W High$175.77
52W Low$100.99
Overview

Repligen Corporation (RGEN) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

RGEN · net income · updated Jun 8, 2026

Core profitability metrics

Net income was $48.9M for FY2025 (fiscal year ending 2025-12-31), up 291.6% year-over-year. Net profit margin was 6.6%. Based on available data, Repligen Corporation has been profitable since at least 2012.

FY2025 Net Income$48.9M▲ +291.6% YoY
Trailing 12M (TTM)$51.4Mtrailing 4 quarters sum
Net Profit Margin6.6%$48.9M ÷ $738.3M
YoY Change+291.6%—
5-Year CAGR-4.0%FY2020 → FY2025
FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0
Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · RGEN net income history · RGEN profit margin

Annual net income data

Fiscal YearNet IncomeYoY ChangeNet Margin
FY2025$48.9M▲ +291.6%6.6%
FY2024Loss−$25.5M▼ 171.7%-4.0%
FY2023$35.6M▼ 80.9%5.6%
FY2022$186.0M▲ +45.0%23.2%
FY2021$128.3M▲ +114.1%19.1%

Net income vs peers (Healthcare)

#CompanyNet IncomeYoY
#1
Repligen Corporation
Repligen CorporationYOU
RGEN
$48.9M+291.6%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$26.80B+90.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$20.64B+94.9%#4
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$12.06B-16.3%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$4.23B-1.2%
Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Repligen Corporation (RGEN) reported net income of $48.9M for FY2025 (fiscal year ending 2025-12-31), up 291.6% year-over-year. The net profit margin was 6.6% — meaning the company kept $0.07 of every dollar of revenue as profit.

Based on available data, Repligen Corporation has been profitable since at least 2012. Net income reached a peak of $186.0M in FY2022. Data available for 15 fiscal years.

Repligen Corporation's net profit margin was 6.6% for FY2025, based on the latest annual results.

Investors sometimes search for "Repligen Corporation net worth" — the company's market capitalization is a separate figure from RGEN net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.
RevenueFinancial statementsEarningsForecastPrice historyMarket capFree cash flow

Frequently asked questions

RGEN net income · 5 questions

Repligen Corporation is profitable. The company reported net income of $48.9M for FY2025, a net profit margin of 6.6%. Net income was up 291.6% year-over-year. Based on available data, Repligen Corporation has been profitable since at least 2012.

is RGEN profitabledoes RGEN make a profitRGEN profitabilityRGEN profitable company

▸ Source: FMP /income-statement · GAAP · Repligen Corporation · Repligen Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026